IceCure Medical develops and markets minimally invasive cryoablation therapies for womens health and general oncology market. Our proprietary IceSense3™ and ProSense systems provide minimally invasive, in-office definitive treatment for symptomatic tumors in various organs. The procedure is an attractive alternative to the current standard treatment of open surgical excision. The procedure is done under ultrasound or CT imaging to guide a small probe (thin hollow needle) into the tumor. The system then uses extremely cold temperatures to destroy (ablate) the targeted tumor in situ. The cryoablation procedure is a safe and effective treatment option that can be performed in a short time in the comfort of a doctors office.